This study aimed to determine the epidemiology of gram-negative bacteria (GNB) isolated in the newborn intensive care unit (NICU) population, to assess their antibiotic susceptibility patterns and possible associated risk factors.
Methods:
All neonates admitted to the NICU of Abderrezak-Bouhara hospital (Skikda, Algeria) with a clinical diagnosis of neonatal infections from March to May 2019 were included in the study. The extended-spectrum β-lactamase (ESBLs), plasmidic cephalosporinase (pAmpC), and carbapenemases genes were screened by polymerase chain reaction (PCR) and sequencing. PCR amplification of oprD among carbapenem-resistant Pseudomonas aeruginosa isolates was also performed. The clonal relatedness of the ESBLs isolates was studied using multilocus sequence typing (MLST).
Results:
Among 148 clinical specimens, 36 (24.3%) GNB strains were isolated from urine (n = 22), wound (n = 8), stool (n = 3), and blood (n = 3) samples. The bacterial species identified were Escherichia coli (n = 13), Klebsiella pneumoniae (n = 5), Enterobacter cloacae (n = 3), Serratia marcescens (n = 3), Salmonella spp. (n = 3), Proteus mirabilis (n = 1), P. aeruginosa (n = 5), and Acinetobacter baumannii (n = 3). PCR and sequencing showed that eleven Enterobacterales isolates harbored the blaCTX-M-15 gene, two E. coli isolates harbored the blaCMY-2 gene, and three A. baumannii isolates harbored both blaOXA-23 and blaOXA-51 genes. Also, five strains of P. aeruginosa were found to harbor mutations in the oprD gene. MLST showed that the K. pneumoniae strains belonged to ST13 and ST189, E. coli belonged to ST69, and E. cloacae belonged to ST214. Different risk factors that could predict positive GNB cultures were found, including female sex, Apgar score <8 at 5 min of life, enteral nutrition, antibiotic use, and extended length of hospitalization.
Conclusion:
Our study highlights the importance of determining the epidemiology of pathogens causing neonatal infections, their sequence types (ST), and their antibiotic susceptibility patterns to address rapidly a correct antibiotic treatment regimen.
Get full access to this article
View all access options for this article.
References
1.
ArhouneB, El FakirS, HimriS, et al.Intense intestinal carriage and subsequent acquisition of multidrug-resistant enterobacteria in neonatal intensive care unit in Morocco. PLoS One, 2021; 16(6):e0251810; doi: 10.1371/journal.pone.0251810
2.
HoJ, TambyahPA, PatersonDL. Multiresistant Gram-negative infections: A global perspective. Curr Opin Infect Dis, 2010; 23(6):546–553; doi: 10.1097/QCO.0b013e32833f0d3e
3.
CarvalhoI, SilvaN, CarrolaJ, et al.Antibiotic resistance. Immunity-acquired resistance: evolution of antimicrobial resistance among extended-spectrum β-lactamases and carbapenemases in Klebsiella pneumoniae and Escherichia coli. In: Antibiotic Drug Resistance. John Wiley & Sons, Ltd; 2019; pp. 239–259; doi: 10.1002/9781119282549.ch11
4.
BarraudO, PeyreM, Couvé-DeaconE, et al.Antibiotic resistance acquisition in the first week of life. Front Microbiol, 2018; 9:1467; doi: 10.3389/fmicb.2018.01467
5.
ChuS-M, HsuJ-F, LaiM-Y, et al.Risk factors of initial inappropriate antibiotic therapy and the impacts on outcomes of neonates with Gram-negative bacteremia. Antibiotics, 2020; 9(4):203; doi: 10.3390/antibiotics9040203
6.
ClockSA, FerngY-H, TabibiS, et al.Colonization with antimicrobial-resistant Gram-negative bacilli at neonatal intensive care unit discharge. J Pediatric Infect Dis Soc, 2017; 6(3):219–226; doi: 10.1093/jpids/piw014
7.
TsaiM-H, LeeI-T, ChuS-M, et al.Clinical and molecular characteristics of neonatal extended-spectrum β-lactamase-producing Gram-negative bacteremia: A 12-year case-control-control study of a referral center in Taiwan. PLoS One, 2016; 11(8):e0159744; doi: 10.1371/journal.pone.0159744
8.
SolomonS, AkejuO, OdumadeOA, et al.Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. PLoS One, 2021; 16(8):e0255410; doi: 10.1371/journal.pone.0255410
9.
TangY-H, JengM-J, WangH-H, et al.Risk factors and predictive markers for early and late-onset neonatal bacteremic sepsis in preterm and term infants. J Chin Med Assoc, 2022; 85(4):507–513; doi: 10.1097/JCMA.0000000000000681
10.
MairiA, MeyerS, TilloyV, et al.Whole genome sequencing of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from neonatal bloodstream infections at a neonatal care unit, Algeria. Microb Drug Resist, 2022; 28(8):867–876; doi: 10.1089/mdr.2021.0337
Herreros FernándezML, González MerinoN, Tagarro GarcíaA, et al.A new technique for fast and safe collection of urine in newborns. Arch Dis Child, 2013; 98(1):27–29; doi: 10.1136/archdischild-2012-301872
13.
European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 12, 2022. Available from: https://www.eucast.org/clinical_breakpoints [Last accessed: November 19, 2022].
14.
European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect, 2003; 9(8):ix–xv; doi: 10.1046/j.1469-0691.2003.00790.x
15.
JarlierV, NicolasMH, FournierG, et al.Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis, 1988; 10(4):867–878; doi: 10.1093/clinids/10.4.867
16.
ReulandEA, HaysJP, de JonghDMC, et al.Detection and occurrence of plasmid-mediated AmpC in highly resistant Gram-negative rods. PLoS One, 2014; 9(3):e91396; doi: 10.1371/journal.pone.0091396
17.
PierceVM, SimnerPJ, LonswayDR, et al.Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol, 2017; 55(8):2321–2333; doi: 10.1128/JCM.00193-17
18.
YaiciL, HaenniM, MétayerV, et al.Spread of ESBL/AmpC-producing Escherichia coli and Klebsiella pneumoniae in the community through ready-to-eat sandwiches in Algeria. Int J Food Microbiol, 2017; 245:66–72; doi: 10.1016/j.ijfoodmicro.2017.01.011
19.
YousfiK, TouatiA, LefebvreB, et al.Characterization of multidrug-resistant Gram-negative bacilli isolated from hospitals effluents: First report of a blaOXA-48-like in Klebsiella oxytoca, Algeria. Braz J Microbiol, 2018; 50(1):175–183; doi: 10.1007/s42770-018-0010-9
20.
Rodríguez-MartínezJ-M, PoirelL, NordmannP. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother, 2009; 53(11):4783–4788; doi: 10.1128/AAC.00574-09
21.
Institut Pasteur MLST Databases and Software. Available from: https://bigsdb.pasteur.fr [Last accessed: November 19, 2022].
22.
OkomoU, AkpaluENK, Le DoareK, et al.Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: A systematic review and meta-analysis in line with the STROBE-NI reporting guidelines. Lancet Infect Dis, 2019; 19(11):1219–1234; doi: 10.1016/S1473-3099(19)30414-1
23.
NebbiosoA, OgundipeOF, RepettoEC, et al.When first line treatment of neonatal infection is not enough: Blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic. BMC Pediatr, 2021; 21(1):570; doi: 10.1186/s12887-021-02911-w
24.
BelbelZ, ChettibiH, DekhilM, et al.Outbreak of an armA methyltransferase-producing ST39 Klebsiella pneumoniae clone in a pediatric Algerian Hospital. Microb Drug Resist, 2014; 20(4):310–315; doi: 10.1089/mdr.2013.0193
25.
IabadeneH, MessaiY, AmmariH, et al.Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J Antimicrob Chemother, 2008; 62(1):133–136; doi: 10.1093/jac/dkn145
26.
MessaiY, IabadeneH, BenhassineT, et al.Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol Biol (Paris), 2008; 56(5):319–325; doi: 10.1016/j.patbio.2008.05.008
27.
NedjaiS, BarguiguaA, DjahmiN, et al.Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria. Med Mal Infect, 2012; 42(1):20–29; doi: 10.1016/j.medmal.2011.10.001
28.
NedjaiS, BarguiguaA, DjahmiN, et al.Prevalence and characterization of extended spectrum beta-lactamase-producing Enterobacter cloacae strains in Algeria. J Infect Dev Ctries, 2013; 7(11):804–811; doi: 10.3855/jidc.3127
29.
ZenatiF, BarguiguaA, NaymeK, et al.Characterization of uropathogenic ESBL-producing Escherichia coli isolated from hospitalized patients in western Algeria. J Infect Dev Ctries, 2019; 13(4):291–302; doi: 10.3855/jidc.10702
30.
SounaD, DrissiM, AlmahmoudI, et al.Enterobacter cloacae complex and CTX-M extended-spectrum β-lactamases in Algeria. Microb Drug Resist, 2022; 28(3):346–354; doi: 10.1089/mdr.2020.0535
31.
BoudjemaaH, AllemR, FonkouMDM, et al.Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria. J Glob Antimicrob Resist, 2019; 18:249–256; doi: 10.1016/j.jgar.2019.01.030
32.
IabadeneH, MessaiY, AmmariH, et al.Prevalence of plasmid-mediated AmpC β-lactamases among Enterobacteriaceae in Algiers hospitals. Int J Antimicrob Agents, 2009; 34(4):340–342; doi: 10.1016/j.ijantimicag.2009.05.011
33.
SounaD, AmirAS, BekhouchaSN, et al.Molecular typing and characterization of TEM, SHV, CTX-M, and CMY-2 β-lactamases in Enterobacter cloacae strains isolated in patients and their hospital environment in the west of Algeria. Med Mal Infect, 2014; 44(4):146–152; doi: 10.1016/j.medmal.2014.01.008
34.
ZemmourA, Dali-YahiaR, MaatallahM, et al.High-risk clones of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from the University Hospital Establishment of Oran, Algeria (2011-2012). PLoS One, 2021; 16(7):e0254805; doi: 10.1371/journal.pone.0254805
35.
BachiriT, BakourS, LalaouiR, et al.Occurrence of carbapenemase-producing Enterobacteriaceae isolates in the wildlife: First report of OXA-48 in Wild Boars in Algeria. Microb Drug Resist, 2018; 24(3):337–345; doi: 10.1089/mdr.2016.0323
36.
MairiA, PantelA, OusalemF, et al.OXA-48-producing Enterobacterales in different ecological niches in Algeria: Clonal expansion, plasmid characteristics and virulence traits. J Antimicrob Chemother, 2019; 74(7):1848–1855; doi: 10.1093/jac/dkz146
37.
MartakD, HenriotCP, BroussierM, et al.High prevalence of human-associated Escherichia coli in wetlands located in Eastern France. Front Microbiol, 2020; 11:552566.
38.
BachiriT, BakourS, LadjouziR, et al.High rates of CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in wild boars and Barbary macaques in Algeria. J Glob Antimicrob Resist, 2017; 8:35–40; doi: 10.1016/j.jgar.2016.10.005
39.
KhennouchiNC, elH, LoucifL, BoutefnouchetN, et al.MALDI-TOF MS as a tool to detect a nosocomial outbreak of extended-spectrum-β-lactamase- and ArmA methyltransferase-producing Enterobacter cloacae clinical isolates in Algeria. Antimicrob Agents Chemother, 2015; 59(10):6477–6483; doi: 10.1128/AAC.00615-15
40.
de Oliveira CostaP, AttaEH, da SilvaARA. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: Risk factors and outcomes. J Pediatr, 2015; 91(5):435–441; doi: 10.1016/j.jped.2014.11.009
41.
BakourS, TouatiA, BachiriT, et al.First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals. J Infect Chemother, 2014; 20(11):696–701; doi: 10.1016/j.jiac.2014.07.010
42.
BouguenounW, BakourS, BentorkiAA, et al.Molecular epidemiology of environmental and clinical carbapenemase-producing Gram-negative bacilli from hospitals in Guelma, Algeria: Multiple genetic lineages and first report of OXA-48 in Enterobacter cloacae. J Glob Antimicrob Resist, 2016; 7:135–140; doi: 10.1016/j.jgar.2016.08.011
43.
BourafaN, ChaalalW, BakourS, et al.Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria. Infect Drug Resist, 2018; 11:735–742; doi: 10.2147/IDR.S150005
44.
MelloukFZ, BakourS, MeradjiS, et al.First detection of VIM-4-producing Pseudomonas aeruginosa and OXA-48-producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria. Microb Drug Resist, 2017; 23(3):335–344; doi: 10.1089/mdr.2016.0032
45.
RamoulA, LoucifL, BakourS, et al.Co-occurrence of blaNDM-1 with blaOXA-23 or blaOXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria. J Glob Antimicrob Resist, 2016; 6:136–141; doi: 10.1016/j.jgar.2016.05.003
46.
TouatiM, DieneSM, RacheracheA, et al.Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int J Antimicrob Agents, 2012; 40(1):89–91; doi: 10.1016/j.ijantimicag.2012.03.017
47.
YagoubatM, Ould El-Hadj-KhelilA, MalkiA, et al.Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria. J Glob Antimicrob Resist, 2017; 8:55–59; doi: 10.1016/j.jgar.2016.10.008
48.
ZenatiK, TouatiA, BakourS, et al.Characterization of NDM-1- and OXA-23-producing Acinetobacter baumannii isolates from inanimate surfaces in a hospital environment in Algeria. J Hosp Infect, 2016; 92(1):19–26; doi: 10.1016/j.jhin.2015.09.020
49.
Ocampo-SosaAA, CabotG, RodríguezC, et al.Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish Multicenter Study. Antimicrob Agents Chemother, 2012; 56(4):1703–1713; doi: 10.1128/AAC.05451-11
50.
SefraouiI, BerrazegM, DrissiM, et al.Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012. Microb Drug Resist, 2014; 20(2):156–161; doi: 10.1089/mdr.2013.0161
51.
Tchakal-MesbahiA, MetrefM, SinghVK, et al.Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients. Burns, 2021; 47(8):1833–1843; doi: 10.1016/j.burns.2021.03.005
52.
ZaidiFZ, Dali-YahiaR, ZenatiK, et al.Characterization of VIM-4 producing clinical Pseudomonas aeruginosa isolates from Western Algeria: Sequence type and Class 1 integron description. Microb Drug Resist, 2020; 26(12):1437–1441; doi: 10.1089/mdr.2019.0225
53.
Lona-ReyesJC, Pérez-RamírezRO, Rodríguez-PatiñoV, et al.[Prevalence of extended-spectrum beta-lactamases in enterobacteria of neonatal sepsis and associated factors]. Rev Chilena Infectol, 2019; 36(4):433–441; doi: 10.4067/S0716-10182019000400433
54.
XiaoT, ChenL-P, LiuH, et al.The analysis of etiology and risk factors for 192 cases of neonatal sepsis. Biomed Res Int, 2017; 2017:8617076; doi: 10.1155/2017/8617076
55.
CassettariVC, da SilveiraIR, DropaM, et al.Risk factors for colonisation of newborn infants during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit. J Hosp Infect, 2009; 71(4):340–347; doi: 10.1016/j.jhin.2008.11.019
56.
NagataE, BritoASJ, MatsuoT. Nosocomial infections in a neonatal intensive care unit: Incidence and risk factors. Am J Infect Control, 2002; 30(1):26–31; doi: 10.1067/mic.2002.119823
57.
ShakilS, AliSZ, AkramM, et al.Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Trop Pediatr, 2010; 56(2):90–96; doi: 10.1093/tropej/fmp060
58.
SultanAM, SeliemWA. Identifying risk factors for healthcare-associated infections caused by carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Sultan Qaboos Univ Med J, 2018; 18(1):e75–e80; doi: 10.18295/squmj.2018.18.01.012
